mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.06 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.096 |
0.07 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |